“The current predicament has exposed some structural weaknesses within the EU’s medicines offer chain plus a large dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides explained. She advisable that offer chain issues be resolved in an EU pharmaceutical tac… Read More